Cardiac Imaging: Part 1, MR Pulse Sequences, Imaging Planes, and Basic Anatomy

Department of Imaging Science, University of Rochester Medical Center, 601 Elmwood Ave, Rm 3-4330, Rochester, NY 14642, USA.
American Journal of Roentgenology (Impact Factor: 2.73). 10/2011; 197(4):808-15. DOI: 10.2214/AJR.10.7231
Source: PubMed


OBJECTIVE: MRI is a well-established modality for evaluating congenital and acquired cardiac diseases. This article reviews the latest pulse sequences used for cardiac MRI. In addition, the standard cardiac imaging planes and corresponding anatomy are described and illustrated. CONCLUSION: Familiarity with the basic pulse sequences, imaging planes, and anatomy pertaining to cardiac MRI is essential to formulate optimal protocols and interpretations.

Download full-text


Available from: Daniel Ginat
  • [Show abstract] [Hide abstract]
    ABSTRACT: Congenital thoracic vascular anomalies may involve the thoracic aorta and its branches, pulmonary arteries and veins, as well as the thoracic systemic veins. Technical improvements in multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI), now allow for the noninvasive preoperative and postoperative imaging evaluation of the majority of these anomalies. The addition of 3D imaging provides comprehensive 3D displays for real-time and interactive interpretation and treatment guidance (Hellinger et al. 2011; Kondrachuk et al. 2012; Lee et al. 2010). In this chapter, the current imaging techniques of MDCT and MRI are reviewed, followed by a discussion on the commonly encountered thoracic congenital and acquired mediastinal vascular anomalies in pediatric patients.
    No preview · Chapter · Jan 2013
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: As survival rates continue to increase for patients with childhood and adult malignancies, imaging utilization in these patients will likely increase substantially. It is important to detect disease recurrence and to recognize the potential complications that occur after treatment with oncologic medications and therapeutic radiation. The most common cardiotoxic side effect of the anthracycline drug class is a dose-dependent decline in ejection fraction, which may result in dilated cardiomyopathy. Multiple-uptake gated acquisition (MUGA) scanning plays an important role in diagnosis of this subclinical cardiac dysfunction. Other less common cardiotoxic side effects of chemotherapeutic medications include arrhythmia, myocarditis, coronary artery disease, tamponade, pericarditis, and pericardial effusion. Radiation therapy can also lead to cardiotoxicity when the heart or pericardium is included in the radiation portal. Radiation-induced conditions include pericardial disease, coronary artery disease, valvular disease, and cardiomyopathy. Many of these side effects are asymptomatic until late in the course of the disease. With imaging, these pathologic conditions can often be diagnosed before symptom onset, which may allow early intervention. Radiologists should be familiar with the current knowledge and pathophysiology regarding cardiac complications related to chemotherapy and radiation therapy of malignant neoplasms and the appearances of treatment-related cardiotoxicity that can be found at radiography, nuclear medicine examinations, and cross-sectional imaging. Supplemental material available at © RSNA, 2013.
    Full-text · Article · Oct 2013 · Radiographics
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: The purpose of this study was to compare cardiac MRI-derived parameters of left ventricular (LV) diastolic function between uncomplicated type 2 diabetes mellitus (DM2) and normoglycemic control subjects and to evaluate whether these parameters of LV diastolic function are related to coronary atherosclerosis. Subjects and methods: We prospectively studied 41 subjects with DM2 and 21 normoglycemic control subjects (30 women and 32 men; mean age, 57.2 ± 7.1 [SD] years) with no evidence of overt cardiovascular disease. We used cardiac MRI to measure LV volumes, LV peak filling rate (PFR), and transmitral flow and CT to determine coronary artery calcium scores. Results: Absolute values of the peak filling rate (PFR) were significantly lower in DM2 patients than in control subjects (mean ± SD, 293.2 ± 51.7 vs 375.7 ± 102.8 mL/s, respectively; p < 0.001). Mitral peak E velocities (mean ± SD, 42.8 ± 10.7 vs 48.8 ± 10.4 cm/s; p = 0.040) and peak E velocity-to-peak A velocity ratios (0.88 ± 0.3 vs 1.1 ± 0.3; p = 0.002) were also lower in DM2 patients compared with control subjects. DM2 patients with coronary artery calcification showed a lower PFR normalized to stroke volume (SV) (mean ± SD, 4.4 ± 1.0 vs 5.3 ± 1.4, respectively; p = 0.038) and lower mitral peak E velocities (40.1 ± 11.3 vs 48.0 ± 7.3 cm/s; p = 0.024) than DM2 patients without coronary calcification. PFR normalized to SV was independently associated with the presence of coronary artery calcification (β = -1.5, p = 0.005). Conclusion: DM2 decreases cardiovascular MRI-derived parameters of LV diastolic function. Patients with DM2 and coronary atherosclerosis show a more impaired LV diastolic function than patients without coronary atherosclerosis.
    Full-text · Article · Jun 2014 · American Journal of Roentgenology
Show more